Medtronic (MDT) reported fiscal Q4 adjusted earnings Wednesday of $1.55 per diluted share, down from $1.62 a year earlier.

Analysts polled by FactSet expected $1.54.

Revenue for the quarter ended April 24 was $9.81 billion, up from $8.93 billion a year earlier.

Analysts surveyed by FactSet expected $9.62 billion.

For fiscal 2027, the medical devices maker expects adjusted EPS of $5.90 to $6.00 and organic revenue growth of 6.75% to 7.25%. Analysts polled by FactSet expect adjusted EPS of $6.05.

Shares of the company were up 2.6% in premarket activity.